Mariner Wealth Advisors (Cincinnati)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Mariner Wealth Advisors (Cincinnati)'s BMY Position: Q3 2018 in Review
Mariner Wealth Advisors (Cincinnati) reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q3 2018, selling an estimated $175K and leaving 19,693 shares worth $1.22M. The position accounts for 0.07% of the portfolio, ranked #129.
Mariner Wealth Advisors (Cincinnati) first reported a position in BMY in Q2 2013 and has held it in 20 quarters since. The position peaked at $1.46M in Q3 2017. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.
- Mariner Wealth Advisors (Cincinnati) held 19,693 shares of Bristol-Myers Squibb worth $1.22M as of Q3 2018.
- Mariner Wealth Advisors (Cincinnati) sold 2,951 Bristol-Myers Squibb shares in Q3 2018, an estimated $175K.
- Bristol-Myers Squibb made up 0.07% of Mariner Wealth Advisors (Cincinnati)'s portfolio in Q3 2018, its #129 holding.
- Mariner Wealth Advisors (Cincinnati) first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 20 quarters since.
- Mariner Wealth Advisors (Cincinnati)'s Bristol-Myers Squibb position peaked at $1.46M in Q3 2017.
- 1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.
Based on Mariner Wealth Advisors (Cincinnati)'s 13F filing for Q3 2018, filed 13 Nov 2018.